Triamterene 37.5mg, hydrochlorothiazide 25mg; caps. Triamterene exerts its diuretic effect on the distal renal tubule to inhibit the reabsorption of sodium in exchange for potassium and hydrogen ions.

This combination medication contains potassium-sparing diuretic and thiazide diuretic, prescribed for essential hypertension, and edema due to low potassium level in body. Diabetes and hypertension ...

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application ...

PHILADELPHIA — Lannett announced that it has received approval from the Food and Drug Administration to market its version of a hypertension treatment. The drug maker said its abbreviated new drug ...

Lannett announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide capsules, 12.5mg, a generic equivalent of Watson‘s Microzide capsules.

Unichem laboratories Limited pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (US FDA) for Hydrochlorothiazide Capsules in the strengths of 12 ...

Are you taking Hydrochlorothiazide? Are you aware of the dangers of combining Hydrochlorothiazide with alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and ...

The two drugs were compared in each of 6 patients with cirrhosis and ascites, urinary sodium and potassium being used as a measure of diuretic action. The design of the study attempted to control many ...

Pharmaceutical firm Zydus Cadila on Wednesday said it has received final approval from the US health regulator to market Triamterene and Hydrochlorothiazide capsules, indicated to treat high blood ...

Drug firm Zydus Cadila on February 13 said it has received final approval from the US health regulator to market Triamterene and Hydrochlorothiazide capsules, indicated to treat high blood pressure.